OTC: AAQL
Antiaging Quantum Living Inc.CIK 0001672571 · SIC 7331 · Direct Mail Advertising Services
Antiaging Quantum Living Inc., previously known as Achison Inc., (the “Company”) is a New York corporation formed on December 29, 2014. Our current principal executive office is 135-27 38th Ave #388, Flushing, NY 11354, New York. Tel: 929-990-3255. About this business →
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (PURR 10-K) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade AAQL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 |
|---|---|---|
| Revenues, net | 730,117 | 291,438 |
| Cost of revenues | 417,227 | 56,706 |
| Gross profit | 312,890 | 234,732 |
| Operating expenses: | ||
| Selling and marketing expenses | 335,484 | 12,612 |
| General and administrative expenses | 300,482 | 360,323 |
| Total operating expenses | 635,966 | 372,935 |
| Loss from operations | (323,076) | (138,203) |
| Other income: | ||
| Interest income | 39 | 21 |
| Other income | 4,528 | 10,810 |
| Total other income | 4,567 | 10,831 |
| Loss before income tax | (318,509) | (127,372) |
| Income tax expense | - | 6,000 |
| Net loss | (318,509) | (133,372) |
| Weighted average shares outstanding | ||
| Basic and diluted | 34,275,340 | 29,995,000 |
| Loss per share | ||
| Basic and diluted | (0.0093) | (0.0045) |
| Comprehensive loss: | ||
| Net loss | (318,509) | (133,372) |
| Other comprehensive loss: | ||
| Foreign currency translation adjustment | (1,088) | (7,937) |
| Total comprehensive loss | (319,597) | (141,309) |
Condensed Consolidated Balance Sheets
| Description | June 30, 2026 (Unaudited) | March 31, 2026 (Audited) |
|---|---|---|
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | 608,100 | 503,486 |
| Accounts receivable, net | 744,840 | 30,000 |
| Inventories, net | 342,386 | 219,036 |
| Advances to suppliers | 160,473 | 231,523 |
| Other receivables and current assets | 453,697 | 229,937 |
| Total Current Assets | 2,309,496 | 1,213,982 |
| Non-Current Assets | ||
| Property and equipment, net | 138,341 | 148,215 |
| Intangible assets, net | 12,650 | 12,806 |
| Operating lease right of use asset, net | 799,480 | 347,682 |
| Total Non-Current Assets | 950,471 | 508,703 |
| Total Assets | 3,259,967 | 1,722,685 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current Liabilities | ||
| Accounts payable and accrued expenses | 402,632 | 389,582 |
| Accounts payable related party | 24,324 | - |
| Other payables | 802,791 | 153,364 |
| Due to related parties | 980,000 | 980,000 |
| Taxes payable | 591 | 1,297 |
| Contract liabilities | 523,933 | 97,605 |
| Operating lease liabilities current portion | 52,635 | 51,172 |
| Total Current Liabilities | 2,786,906 | 1,673,020 |
| Non-Current Liabilities | ||
| Operating lease liabilities non-current | 481,071 | 319,621 |
| Long term loans payable | 987,458 | 405,915 |
| Total Non-Current Liabilities | 1,468,529 | 725,536 |
| Total Liabilities | 4,255,435 | 2,398,556 |
| Commitments and Contingencies | - | - |
| Shareholders’ Equity | ||
| Class A Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; 34,275,340 and 29,995,000 shares issued and outstanding at June 30, 2026 and March 31, 2026 | 30,423 | 30,423 |
| Class B Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and March 31, 2026 | - | |
| Class C Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and March 31, 2026 | - | - |
| Class D Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and March 31, 2026 | - | - |
| Class E Common stock, par value $0.00001 per share; 1,200,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and March 31, 2026 | - | - |
| Additional paid-in capital | 1,527,204 | 1,527,204 |
| Accumulated deficit | (2,565,867) | (2,247,358) |
| Accumulated other comprehensive (loss) income | 12,772 | 13,860 |
| Total Shareholders’ Deficit | (995,468) | (675,871) |
| Total Liabilities and Shareholders’ Deficit | 3,259,967 | 1,722,685 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | (318,509) | (133,372) |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation and amortization expense | 10,291 | 35,782 |
| Amortization of operating lease ROU assets | 54,176 | 98,337 |
| Write-off assets | - | 3,934 |
| Changes in assets and liabilities | ||
| Increase in accounts receivable | (712,859) | (187,547) |
| Increase in inventories | (121,528) | - |
| Decrease in advances to suppliers | 74,686 | 16,386 |
| Increase in prepaid expenses | (193,785) | - |
| (Increase) decrease in other receivables and current assets | (7,656) | 1,282 |
| Increase in customer advances | 30,731 | - |
| (Decrease) increase in accounts payable | (63,763) | 14,934 |
| Increase in bank overdraft | 24,253 | - |
| Increase (decrease) in accrued expenses and other payables | 700,050 | (22,655) |
| Increase in taxes payable | - | 6,177 |
| Increase in contract liabilities | 394,453 | - |
| Decrease in operating lease liabilities | (342,224) | (18,000) |
| Net cash used in operating activities | (471,684) | (184,742) |
| Cash flows from investing activities | ||
| Purchase of fixed assets | - | (1,089) |
| Net cash used in investing activities | - | (1,089) |
| Cash flows from financing activities | ||
| Proceeds from borrowings | 573,126 | - |
| Proceeds from related party advances | - | 220,000 |
| Net cash provided by financing activities | 573,126 | 220,000 |
| Net increase of cash and cash equivalents | 101,442 | 34,169 |
| Effect of foreign currency translation on cash and cash equivalents | 3,172 | 1,007 |
| Cash and cash equivalents beginning | 503,486 | 370,549 |
| Cash and cash equivalents ending | 608,100 | 405,725 |
| Supplementary cash flow information: | ||
| Interest paid | - | - |
| Income taxes paid | - | - |
| Non-cash financing and investing activities: | ||
| Recognized ROU assets through lease liabilities | 504,630 | - |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗
About Antiaging Quantum Living Inc.
Source: Item 1 (Business) from the 10-K filed July 14, 2026. Description as filed by the company with the SEC.
Item
1. Business
History
and Overview
Antiaging
Quantum Living Inc., previously known as Achison Inc., (the “Company”) is a New York corporation formed on December 29, 2014.
Our current principal executive office is 135-27 38th Ave #388, Flushing, NY 11354, New York. Tel: 929-990-3255.
On
July 1, 2019 Lansdale Inc, the principal stockholder of the Company (“Seller”) and controlled by the Company’s prior
President, Mr. Wanjun Xie, entered into a Stock Purchase Agreement (the “Agreement”) with Dazhong 368 Inc, (the “Buyer”),
pursuant to which, among other things, Seller agreed to sell to the Buyer, and the Buyer agreed to purchase from Seller, a total of 9,000,000
shares of Class A Common Stock of the Company of record and beneficially by Seller. The Purchased Shares represented approximately 90%
of the Company’s issued and outstanding shares of Class A Common Stock, resulting in a change of the control of the Company. Mr.
Dingshan Zhang was appointed as the President and CEO of the Company at the same date.
3
Prior
to the change of the management team, the Company was engaging in holding or trading securities in the US market, trading spot silver
in Singapore’s market as well as to trade whisky in the UK market. The Company has changed its focus to operate online advertising
business through www.dazhong368.com (the “Website”) in the New York area.
The
Website was established by Mr. Zhang in 2014 which is mainly focused on customers in the Greater New York area. The Website advertises
different markets for professional individuals or companies including real estate, services, accounting, legal and so forth. We charge
certain fees from these advertisements posted on our Website. The Company expects to generate revenue from the online advertising business
and we also seek other profitable business at the same time.
Read full description ↓
On
March 21, 2023, Barry Wan entered into a stock purchase agreement acquiring control of 29,215,000 restricted shares of common stock of
the Company, representing approximately 97.4% of the Company’s total issued and outstanding common stock from Dazhong 368 Inc and
Sophia 33 Inc, two New York corporations controlled by the Company’s then President, Chief Executive Officer and sole director,
Dingshan Zhang (the “transaction”).
On
April 10, 2023, during the closing of the transaction, Barry Wan assigned all his shares to New Lite Ventures LLC (A.K.A. “New
Living Ventures LLC”, “LLC”), a Delaware Limited Liability Company, with which Barry Wan is the sole member. The foregoing
transaction resulted in a change of control of the Company, with LLC 97.4% of the Company’s outstanding Common Stock. Both before
and after the transactions, the Company had 29,995,000 shares of its common stock outstanding.
In
connection with the transaction, on April 10, 2023, Mr. Dingshan Zhang resigned from all positions he held with the Company. On April
10, 2023, Ms. Jing Wan was appointed by our majority shareholder as our Chief Executive Officer, Chief Financial Officer, President and
Director. On June 16, 2023, Mr. Barry Wan was approved by Directors Resolution to act as the new Chief Executive Officer, Chief Financial
Officer, Treasurer, Secretary, and Chairman of the Board of Directors after Ms. Jing Wan resigned. The Company was renamed as Antiaging
Quantum Living Inc. on June 14, 2023 by the new management. Along with the name change, the ticker symbol of the Company was modified
to “AAQL”. The Company plans to continue its existing operations through its website at www.dazhong368.com, which,
since 2014, has provided online advertising to different individuals or companies operating in real estate, accounting, legal and other
professional services in the New York City area. Its revenues are generated from advertising fees.
On
October 4, 2023, the Board of Directors of the Company approved the appointment of PWN LLP to be the new independent registered public
accounting firm, as a result of the competitive selection process to determine the independent registered public accounting firm for
the financial period ending September 30, 2023. The action effectively dismissed Simon & Edward, LLP as the Company’s independent
registered public accounting firm as of October 4, 2023
On
December 29, 2023, the Board of Directors of the Company adopted a resolution to expand its operations into the global market, specifically
targeting the Asia-Pacific and Chinese markets. In line with this expansion, the Company established multiple business entities as follows:
AAQL Inc. (“BVI Holding”), a British Virgin Islands Company wholly owned by the Company, AAQL HK Limited (“Hong Kong
Holding”), a wholly-owned subsidiary of BVI Holding, Antiaging Doctor Hangzhou Holding LTD (“Dao Ling Doctor Hangzhou”),
a wholly-owned subsidiary of Hong Kong Holding, Dao Ling Doctor (Zhejiang) Health Management Limited (“Dao Ling Doctor Zhejiang”),
a wholly-owned subsidiary of Dao Ling Doctor Hangzhou, and Dao Ling Doctor (Huzhou) Health Management Limited ( “Dao Ling Doctor
Huzhou”), a wholly-owned subsidiary of Dao Ling Doctor Hangzhou. Consequently, this transition eventually shifted the Company from
being categorized as a shell company under 17 CFR § 240.12b-2 to an entity actively conducting business operations through its subsidiaries.
Dao
Ling Doctor Zhejiang’s primary business involves providing professional technical development and maintenance services to distributors
of the “Dao Ling Doctor” brand, and collecting technical service fees.
Dao
Ling Doctor Huzhou’s primary business involves providing health consulting services (excluding diagnosis and treatment services),
network and information security software development and big data services, and other services.
On
June 6, 2024, the holders of a majority of the issued and outstanding voting securities of the Company approved, by written consent,
an amendment to its Certificate of Incorporation of the Company to increase in the number of authorized shares of common stock of the
Company from thirty million (30,000,000) shares of common stock, par value $0.001 per share, to six billion (6,000,000,000) shares of
common stock, par value $0.00001 per share (the “Authorized Capital Increase”). Upon the effectiveness of the Authorized
Capital Increase, the shares of common stock will be categorized as follows: 1,200,000,000 Class A shares, 1,200,000,000 Class B shares,
1,200,000,000 Class C shares, 1,200,000,000 Class D shares, and 1,200,000,000 Class E shares.
On
June 6, 2024, the Certificate of Amendment to the Certificate of Incorporation was filed with New York State Department effectuating
the Authorized Capital Increase.
Products
and Services
Our
current services will focus on website development, maintenance and online business advertisement. Meanwhile, we will also search for
different business opportunities to be acquired by the Company.
We
will continue to improve our online platform in order to expand our customer base. The potential customer resource of our online advertising
platform will be mainly from professional individuals and small companies that will use our platform to promote their services or products
to their end-users.
4
Strategy
Our
strategy is to target the small to medium-sized companies as well as the professional individuals that will use our Website to promote
their products or services. Except to build up a customized ID card introduction for each of our customers, we will also help our customers
to maintain their content information posted under their ID card introduction. We hope this one-stop service will better serve our potential
customers.
Competitive
Conditions
The
online advertising industry is highly competitive, rapidly evolving and subject to constant technological change and intense marketing
by providers with similar products and services.
A
few of our competitors have substantially greater financial, technical and marketing resources, larger customer bases, longer operating
histories, greater name recognition and more established relationships in the industry than we have. As a result, certain of these competitors
may be able to adopt more aggressive pricing policies that could hinder our ability to market our services. We believe that our key competitive
advantages are our ability to deliver reliable, high quality service in a cost-effective manner. We cannot provide assurances, however,
that these advantages will enable us to succeed against comparable service offerings from our competitors